History

Fresenius Kabi in India

India

1995

Originally incorporated as “Fresenius Mafatlal Medicals Private Limited.” – Joint venture with Mafatlal Group

1996

Name changed to “Fresenius Mafatlal Medicals Limited.”

1999

Name Changed to Fresenius Kabi India Limited

2000

Became subsidiary of Fresenius Kabi AG

2001

Name Changed to Fresenius Kabi India Private Limited due to conversion from Limited to Private Limited Company

2008

2008

Fresenius Kabi grown its I.V. generics business and expanded into oncology drugs with the Dabur Pharma acquisition.
 

2012

Fresenius Kabi acquired the transfusion technology company Fenwal and created a global leader in transfusion technology with a broad product portfolio for collection and processing of blood components and for therapeutic treatment of patient blood by apheresis systems.

 

2013

Manufacturing Unit of  Goa Formulations Limited in Goa was acquired by Fresenius Kabi India Pvt Ltd.

2016

2016

Fresenius Kabi India Pvt Ltd launched 2 new divisions - EN Outside Market (Enteral Nutrition Products for Out Side Hospital Market) and Kabi Criticare (I.V.Drugs)